ALISITY
Live / Allowed — Third extension granted (statement of use) (as of 11 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98415302
- Mark type
- Word mark
- Filed
- 21 Feb 2024
- Published for opposition
- 15 Oct 2024
- Attorney of record
- Lisa L. Mueller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease
Owner
- PRIOVANT THERAPEUTICS, INC., Durham, NC, US
- PRIOVANT THERAPEUTICS, INC., NEW YORK, NY, US
Prosecution history
- 14 May 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 May 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 May 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 May 2026 — SOU EXTENSION 3 GRANTED
- 11 May 2026 — SOU EXTENSION 3 FILED
- 11 May 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Oct 2025 — SOU EXTENSION 2 GRANTED
- 27 Oct 2025 — SOU EXTENSION 2 FILED
- 27 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2025 — SOU EXTENSION 1 GRANTED
- 28 Apr 2025 — SOU EXTENSION 1 FILED
- 28 Apr 2025 — SOU TEAS EXTENSION RECEIVED